The structural mechanism of HIV-2 Vif antagonism of human APOBEC3H
Human APOBEC3 (A3) proteins restrict retrovirus infection by inducing hypermutations in viral cDNA. To counteract this restriction, lentiviruses, such as HIV-1 and HIV-2 encode the viral infectivity factor (Vif), which hijacks a host Cullin-RING E3 ubiquitin ligase complex to target A3 proteins for proteasomal degradation. Here, we present the cryo-EM structure of HIV-2 Vif in complex with human A3H and CBFβ. The structure reveals that A3H forms a dimer mediated by dsRNA where each A3H monomer directly interacts with an HIV-2 Vif and the host protein CBFβ. Both HIV-2 Vif-A3H and CBFβ-A3H interfaces are critical for A3H degradation. Notably, however, the HIV-2 Vif-A3H interface is entirely distinct from the previously determined cryo-EM structure of the HIV-1 Vif and A3H complex. These findings suggest that HIV-1 and HIV-2 Vif, which are the result of distinct cross-species transmissions from species with different A3H characteristics, have followed separate evolutionary trajectories to counteract human A3H.
Authors
- Estelle K. Ronayne
- John D. Gross (ORCID: https://orcid.org/0000-0002-1377-4705)
- Michael Emerman (ORCID: https://orcid.org/0000-0002-4181-6335)
- Nicholas M. Chesarino (ORCID: https://orcid.org/0000-0002-3582-8508)
- Yange Niu (ORCID: https://orcid.org/0000-0003-1092-8972)
- Michelle Lilly (ORCID: https://orcid.org/0009-0007-4549-316X)
Institutions
- QB3 (US)
- University of Akron (US)
- University of California, San Francisco (US)
- Fred Hutch Cancer Center (US)
- Quantitative BioSciences (US)
- University of San Francisco (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1038/s41467-026-75045-1
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00